Find your path to Tanja
113 people in our graph share verified history with Tanja — schools, employers, funds. One of them is your warm intro.
About
Tanja Dowe is a Managing Director at Angelini Ventures. She previously served as CEO of the Debiopharm Innovation Fund in Lausanne, Switzerland, where she developed a portfolio of digital health and data-driven R&D companies, and earlier was Managing Partner of the life sciences consulting firm Innomedica Ltd and founder-CEO of the market research agency BioSolutions INT. She holds an MSc in Applied Microbiology and Biochemistry from Helsinki University of Technology (now Aalto University).
Contact· self-published, not guessed
Invests in
Digital HealthHealthtech
Experience
- Nobi Smart LightsBoard Membercurrent2025 — present
- Noctrix Health, Inc.Board Observercurrent2024 — presentPleasanton, California, United States
- Angelini VenturesManaging Directorcurrent2023 — present
- ReaktorBoard Member2022 — 2024Helsinki, Finland
- VivoSense, Inc.Board Member2022 — 2023Newport Beach, California, United States
- NovadiscoveryBoard Member2019 — 2023Lyon, France
- Debiopharm International SACEO, Debiopharm Innovation Fund S.A.2017 — 2023Lausanne, Switzerland
- Debiopharm International SAHead of Debiopharm Innovation Fund2016 — 2017Lausanne, Switzerland
- OncomfortBoard Member2022 — 2023Wavre, Belgium
- OncomfortChairwoman of the Board2020 — 2021Wavre, Belgium
- VoluntisBoard Observer2020 — 2021Paris, France
- Kaiku HealthChairwoman of the Board2019 — 2020Helsinki, Finland
- Kaiku HealthBoard Member2018 — 2019
- GenePOCChairwoman of the Board2017 — 2019Québec, Quebec, Canada
- GenePOCBoard Member2016 — 2017Québec, Quebec, Canada
- Living Factories programme - Synthetic Biology for a sustainable BioeconomyMember of the Steering Board2015 — 2016
- Innomedica LtdManaging Partner2012 — 2016Helsinki & London, Lund, Tokyo, Zürich
- Innomedica LtdManaging Director2009 — 2011Helsinki, Finland
- Innomedica LtdVice President, Business Development; Manager, Market Intelligence2002 — 2009Helsinki, Finland
- BioSolutions INTEntrepreneur, CEO2000 — 2002Helsinki, Finland & San Diego, USA
- TekesIndustry Analyst1999 — 2000Los Angeles
- FinproIntern, Assistant to the Trade Commissioner1998Toronto
Skills & more
+12 more
MicrobiologyDrug DevelopmentInternational BusinessInnovation ManagementTechnology TransferPharmaceutical IndustryEntrepreneurshipClinical TrialsLicensingBusiness PlanningBusiness StrategyValuationLanguages English · Finnish · French · German · Swedish · Swiss-German
From Tanja's professional profile.
Colleagues at Angelini Ventures
Frequently asked questions
- Who is Tanja Dowe?
- Tanja Dowe is a Managing Director at Angelini Ventures. She previously served as CEO of the Debiopharm Innovation Fund in Lausanne, Switzerland, where she developed a portfolio of digital health and data-driven R&D companies, and earlier was Managing Partner of the life sciences consulting firm Innomedica Ltd and founder-CEO of the market research agency BioSolutions INT. She holds an MSc in Applied Microbiology and Biochemistry from Helsinki University of Technology (now Aalto University).
- Where does Tanja Dowe work?
- Tanja Dowe is Managing Director at Angelini Ventures.
- What does Tanja Dowe invest in?
- Tanja Dowe invests in Digital Health, Healthtech.
- Where did Tanja Dowe go to school?
- Tanja Dowe studied at Teknillinen korkeakoulu-Tekniska högskolan (MSc Tech., Major: Applied microbiology; Minors: biochemistry, bioprocess engineering).
Same school
Also attended Teknillinen korkeakoulu-Tekniska högskolan76
+ 70 more
Shared employers
Also worked at Noctrix Health, Inc.7
+ 1 more
Also worked at Reaktor9
+ 3 more

































